Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study
- PMID:28042600
- PMCID: PMC5155077
- DOI: 10.1155/2016/3194010
Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study
Abstract
Bacillary dysentery is a major cause of children's admission to hospitals. To assess the probiotic and prebiotic (synbiotics) effects in children with dysentery in a randomized clinical trial, 200 children with dysentery were studied in 2 groups: the synbiotic group received 1 tablet/day of synbiotic for 3-5 days and the placebo group received placebo tablets (identical tablet form like probiotics). The standard treatment was administered for all patients. Duration of hospitalization, dysentery, fever, and the weight loss were assessed in each group. It was concluded that there was no significant difference in both groups in the baseline characteristics. The mean duration of dysentery reduced (P < 0.05). The mean duration of fever has been significantly reduced in the synbiotic group (1.64 ± 0.87 days) in comparison to the placebo group (2.13 ± 0.94 days) (P < 0.001). Average amount of weight loss was significantly lower in the synbiotic group in comparison to that in the placebo group (129.5 ± 23.388 grams and 278 ± 28.385 grams, resp.;P < 0.001). There was no significant difference in the mean duration of hospitalization in both groups (P > 0.05). The use of synbiotics as an adjuvant therapy to the standard treatment of dysentery significantly reduces the duration of dysentery, fever, and rate of weight losses. The trial is registered with IRCT201109267647N1.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
- Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea.Passariello A, Terrin G, Cecere G, Micillo M, De Marco G, Di Costanzo M, Cosenza L, Leone L, Nocerino R, Canani RB.Passariello A, et al.Aliment Pharmacol Ther. 2012 Apr;35(7):782-8. doi: 10.1111/j.1365-2036.2012.05015.x. Epub 2012 Feb 13.Aliment Pharmacol Ther. 2012.PMID:22324448Clinical Trial.
- Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.Baştürk A, Artan R, Yılmaz A.Baştürk A, et al.Turk J Gastroenterol. 2016 Sep;27(5):439-443. doi: 10.5152/tjg.2016.16301.Turk J Gastroenterol. 2016.PMID:27782892Clinical Trial.
- Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial.Shafiei A, Moin M, Pourpak Z, Gharagozlou M, Aghamohammadi A, Sajedi V, soheili H, Sotoodeh S, Movahedi M.Shafiei A, et al.Iran J Allergy Asthma Immunol. 2011 Mar;10(1):21-8.Iran J Allergy Asthma Immunol. 2011.PMID:21358011Clinical Trial.
- Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE.Manzanares W, et al.Crit Care. 2016 Aug 19;19:262. doi: 10.1186/s13054-016-1434-y.Crit Care. 2016.PMID:27538711Free PMC article.Review.
- Fermented cereal beverages: from probiotic, prebiotic and synbiotic towards Nanoscience designed healthy drinks.Salmerón I.Salmerón I.Lett Appl Microbiol. 2017 Aug;65(2):114-124. doi: 10.1111/lam.12740. Epub 2017 Jun 7.Lett Appl Microbiol. 2017.PMID:28378421Review.
Cited by
- Prophylactic Potential of Synbiotic (Lactobacillus casei and Inulin) in Malnourished Murine Giardiasis: an Immunological and Ultrastructural Study.Shukla G, Sharma A, Bhatia R, Sharma M.Shukla G, et al.Probiotics Antimicrob Proteins. 2019 Mar;11(1):165-174. doi: 10.1007/s12602-017-9368-5.Probiotics Antimicrob Proteins. 2019.PMID:29260483
- Antiamoebic drugs for treating amoebic colitis.Gonzales MLM, Dans LF, Sio-Aguilar J.Gonzales MLM, et al.Cochrane Database Syst Rev. 2019 Jan 9;1(1):CD006085. doi: 10.1002/14651858.CD006085.pub3.Cochrane Database Syst Rev. 2019.PMID:30624763Free PMC article.
References
- Niyogi S. K. Shigellosis. Journal of Microbiology. 2005;43(2):133–143. - PubMed
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources